Biophytis S.A. (BPTSY)
USD 3.05
(0.0%)
USD 3.05
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 9.13 Million EUR | -41.29% |
| 2022 | 15.56 Million EUR | -22.05% |
| 2021 | 19.96 Million EUR | 8.48% |
| 2020 | 18.4 Million EUR | 17.39% |
| 2019 | 15.67 Million EUR | 96.12% |
| 2018 | 7.99 Million USD | 5311.65% |
| 2017 | 147.69 Thousand USD | -87.14% |
| 2016 | 1.14 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q2 | 13.99 Million EUR | 0.0% |
| 2023 FY | 9.13 Million EUR | -41.29% |
| 2023 Q4 | 9.13 Million EUR | 0.0% |
| 2022 Q2 | 19.78 Million USD | 0.0% |
| 2022 Q4 | 15.56 Million EUR | 0.0% |
| 2021 Q2 | 21.54 Million USD | 0.0% |
| 2021 Q4 | 21.22 Million USD | 0.0% |
| 2020 Q4 | 11.12 Million USD | 0.0% |
| 2020 Q2 | 11.3 Million USD | 0.0% |
| 2019 Q4 | 15.67 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | 77.828% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -121.629% |
| SQZ Biotechnologies Company | 27.47 Million USD | 66.745% |
| Evofem Biosciences, Inc. | 43.37 Million USD | 78.937% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | 69.31% |
| Mesoblast Limited | 118.7 Million USD | 92.304% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -863.38% |
| Genus plc | 233.1 Million USD | 96.081% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -211.749% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -579.932% |
| Marizyme, Inc. | 18.71 Million USD | 51.193% |
| ContraFect Corporation | 2.88 Million USD | -217.093% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -1118.061% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -6642.68% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -531.635% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -292.761% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -61.451% |
| MultiCell Technologies, Inc. | 202.58 USD | -4509454.25% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | 84.109% |
| EV Biologics, Inc. | 1.49 Million USD | -511.169% |
| Q BioMed Inc. | 4.1 Million USD | -122.275% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | 72.401% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -1349.895% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -643.711% |
| Biomind Labs Inc. | 735.54 Thousand USD | -1142.003% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 171.54 Million USD | 94.675% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | 29.711% |
| Skye Bioscience, Inc. | 4.61 Million USD | -97.94% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -928.693% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -6355.331% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -55.601% |
| IMV Inc. | 28.88 Million USD | 68.372% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -35420.257% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -304.513% |
| GB Sciences, Inc. | 1.75 Million USD | -419.264% |
| Alpha Cognition Inc. | 1.22 Million USD | -648.58% |
| HST Global, Inc. | 98.31 Thousand USD | -9191.648% |
| CSL Limited | 12.18 Billion USD | 99.925% |
| Halberd Corporation | 150 Thousand USD | -5990.303% |
| Enzolytics Inc. | 996.33 Thousand USD | -816.903% |
| Resverlogix Corp. | 6.49 Million USD | -40.74% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 477.5 Thousand USD | -1813.184% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -3474.234% |
| argenx SE | 20 Million USD | 54.323% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | 79.949% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -237.263% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -89244.303% |
| Genscript Biotech Corporation | 417.73 Million USD | 97.813% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -4453.702% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -281.005% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -3884.219% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 86.495% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -201.88% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -2439.672% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | 55.06% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -6045.448% |
| BioStem Technologies, Inc. | 4.71 Million USD | -93.9% |
| ONE Bio Corp. | 19.71 Million USD | 53.662% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -3551.524% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -3572.988% |
| Agentix Corp. | 50 Thousand USD | -18170.91% |
| LadRx Corporation | 33.6 Thousand USD | -27084.0% |
| Cell Source, Inc. | 9.25 Million USD | 1.283% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -1108.068% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -1108.068% |
| NovAccess Global Inc. | 2.19 Million USD | -315.271% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -29.163% |
| Itoco Inc. | 228.37 Thousand USD | -3900.164% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -4230.113% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -83.332% |
| Kadimastem Ltd | 891.22 Thousand USD | -925.044% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -2173.355% |
| CytoDyn Inc. | 30.07 Million USD | 69.625% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | -1786.384% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -2496.428% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -16.822% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -7357.514% |
| Rebus Holdings, Inc. | 310 Thousand USD | -2846.921% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -92.923% |
| International Stem Cell Corporation | 4.17 Million USD | -118.656% |
| Bioxytran, Inc. | 1.92 Million USD | -374.569% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -14537.103% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -318.885% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -9.854% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -6.412% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -487.308% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -3308.752% |
| Neutra Corp. | 54.15 Thousand USD | -16768.777% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -399.205% |
| PureTech Health plc | 25.51 Million USD | 64.192% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -646.223% |
| IXICO plc | 472.02 Thousand USD | -1835.383% |
| IntelGenx Technologies Corp. | 15.5 Million USD | 41.065% |
| Gelesis Holdings, Inc. | 62.26 Million USD | 85.328% |
| CSL Limited | 12.18 Billion USD | 99.925% |
| Cellectis S.A. | 92.77 Million USD | 90.153% |